The Oncology Institute, Inc. TOI Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $33.57M-32.4% | $49.67M+48.3% | $33.49M+139% | $14.01M-87.8% | ||
| $223.62M+3.7% | $215.61M+17.7% | $183.15M+43.0% | $128.1M+429% | ||
| $63.85M+48.4% | $43.02M-10.9% | $48.27M+35.5% | $35.63M+358% | ||
| $112.75M+0.3% | $112.42M-21.7% | $143.49M+10.0% | $130.42M-15.3% | ||
| $10.68M-10.1% | $11.89M+9.2% | $10.88M+27.3% | $8.55M+104% | ||
| $7.23M0.0% | $7.23M0.0% | $7.23M-66.2% | $21.42M-19.6% | ||
| $11.02M-25.6% | $14.81M-17.3% | $17.9M-0.3% | $17.96M-1.6% | ||
| $164.66M-4.7% | $172.72M-17.5% | $209.24M-20.0% | $261.67M+28.6% | ||
| $43.17M+77.5% | $24.32M+68.6% | $14.43M+54.0% | $9.37M-39.8% | ||
| —— | —— | —— | $0-100% | ||
| $70.96M+35.9% | $52.22M+50.1% | $34.79M+17.1% | $29.72M-0.3% | ||
| $77.4M-16.9% | $93.13M+7.3% | $86.83M+7.7% | $80.62M— | ||
| $180.38M+6.7% | $169.13M+11.1% | $152.22M+9.9% | $138.49M+39.5% | ||
| 500M+6,249,900% | 8K0.0% | 8K+14.3% | 7K0.0% | ||
| -$271.42M-28.7% | -$210.81M-44.2% | -$146.15M-132% | -$63.08M+0.2% | ||
| -$15.72M-538% | $3.59M-93.7% | $57.03M-53.7% | $123.18M+18.3% | ||
| $164.66M-4.7% | $172.72M-17.5% | $209.24M-20.0% | $261.67M+28.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are The Oncology Institute, Inc.'s total assets?
- The Oncology Institute, Inc. (TOI) holds $168.2M in total assets, up 2.6% year over year.
- How much debt does The Oncology Institute, Inc. have?
- The Oncology Institute, Inc. carries $104.9M in total debt against -$16.3M of shareholders' equity, a debt-to-equity ratio of 20.21.
- How much cash does The Oncology Institute, Inc. have?
- The Oncology Institute, Inc. holds $30.3M in cash and equivalents.
- Can The Oncology Institute, Inc. cover its short-term obligations?
- Its current ratio is 1.47 — current assets exceed current liabilities.
- Where does The Oncology Institute, Inc.'s balance sheet data come from?
- Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
